These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10591692)

  • 21. [The modern treatment of myocardial infarction by coronary reperfusion: impact on the organization of care].
    Grosgogeat Y; Artigou JY
    Bull Acad Natl Med; 1991 Mar; 175(3):385-92; discussion 392-3. PubMed ID: 1933463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infarct angioplasty: beyond stents and glycoprotein IIb/IIIa inhibitors.
    Dixon SR
    Heart; 2005 Jun; 91 Suppl 3(Suppl 3):iii2-6. PubMed ID: 15919647
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute coronary syndrome: ST segment elevation myocardial infarction.
    Grech ED; Ramsdale DR
    BMJ; 2003 Jun; 326(7403):1379-81. PubMed ID: 12816828
    [No Abstract]   [Full Text] [Related]  

  • 24. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 25. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals.
    Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Kochman W; Korecki J; Poniatowski B; Zuk J; Sitniewska E; Bachorzewska-Gajewska H; Sienkiewicz J; Musial WJ
    Eur Heart J; 2007 Oct; 28(20):2438-48. PubMed ID: 17884846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of pre-hospital use of glycoprotein IIb/IIIa inhibitors in ST-segment elevation myocardial infarction before mechanical reperfusion in a rapid-transfer network (from the Acute Myocardial Infarction Registry of Brittany).
    Auffret V; Oger E; Leurent G; Filippi E; Coudert I; Hacot JP; Castellant P; Rialan A; Delaunay R; Rouault G; Druelles P; Boulanger B; Treuil J; Avez B; Bedossa M; Boulmier D; Le Guellec M; Le Breton H
    Am J Cardiol; 2014 Jul; 114(2):214-23. PubMed ID: 24878117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycoprotein IIb/IIIa inhibition.
    Klein J
    JAMA; 2004 Nov; 292(18):2211; author reply 2211-2. PubMed ID: 15536101
    [No Abstract]   [Full Text] [Related]  

  • 28. Sonothrombolysis: a universally applicable and better way to treat acute myocardial infarction and stroke? Who is going to fund the research?
    Kaul S
    Circulation; 2009 Mar; 119(10):1358-60. PubMed ID: 19255337
    [No Abstract]   [Full Text] [Related]  

  • 29. Improving microvascular perfusion with platelet glycoprotein IIb/IIIa receptor inhibition.
    Dippel EJ
    J Invasive Cardiol; 2002 Dec; 14 Suppl E():12E-16E; quiz 17E. PubMed ID: 12668858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycoprotein IIb/IIIa inhibition.
    Horton H
    JAMA; 2004 Nov; 292(18):2211; author reply 2211-2. PubMed ID: 15536102
    [No Abstract]   [Full Text] [Related]  

  • 31. Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies.
    Waters RE; Mahaffey KW; Granger CB; Roe MT
    Am Heart J; 2003 Dec; 146(6):958-68. PubMed ID: 14660986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of therapeutic trends in myocardial infarction.
    Milasinovic D; Teischinger L; Luerzer G; Mohl W
    Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):15-9. PubMed ID: 19618592
    [No Abstract]   [Full Text] [Related]  

  • 33. STEMI interventions--a review of relevant clinical trials.
    Mehta S; Patlola RR; Cohen S; Falcao E; Flores AI; Soles EO
    Indian Heart J; 2009; 61(2):191-206. PubMed ID: 20039507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence.
    Singh S; Gopal AK; Bahl VK
    Indian Heart J; 2005; 57(3):201-9. PubMed ID: 16196176
    [No Abstract]   [Full Text] [Related]  

  • 35. Platelet disaggregation: putting time on your side in acute myocardial infarction.
    Simon DI; Sakuma M
    J Am Coll Cardiol; 2004 Jul; 44(2):324-6. PubMed ID: 15261926
    [No Abstract]   [Full Text] [Related]  

  • 36. New era of reperfusion in acute myocardial infarction.
    Kline-Rogers E; Martin JS; Smith DD
    Crit Care Nurse; 1999 Feb; 19(1):21-31; quiz 32-3. PubMed ID: 10401288
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of selective infarct-related artery infusion of tirofiban on myocardial reperfusion and bleeding complications in patients with acute myocardial infarction: the SUIT-AMI trial.
    Chen Y; Zhou P; Yan H; Zhao H; Song L; Liu C; Zhao B; Chi Y; Wang S; Wang J
    J Invasive Cardiol; 2013 Aug; 25(8):376-82. PubMed ID: 23913601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing outcomes with a pharmacoinvasive strategy: is there a role for glycoprotein IIb/IIIa receptor antagonists?
    Abbott JD; Shah S
    Catheter Cardiovasc Interv; 2011 Sep; 78(3):385-6. PubMed ID: 21976429
    [No Abstract]   [Full Text] [Related]  

  • 39. [Management of acute myocardial infarction. How improve primary angioplasty?].
    Commeau P
    Presse Med; 2011 Jun; 40(6):606-10. PubMed ID: 21498034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction.
    Huber K; De Caterina R; Kristensen SD; Verheugt FW; Montalescot G; Maestro LB; Van de Werf F;
    Eur Heart J; 2005 Oct; 26(19):2063-74. PubMed ID: 16055497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.